The α2δ Subunit and Absence Epilepsy: Beyond Calcium Channels?

Roberta Celli , Ines Santolini , Michela Guiducci , Gilles van Luijtelaar
Current Neuropharmacology 15 ( 6) 918 -925

11
2017
Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage

Slavianka G Moyanova , Federica Mastroiacovo , Lidia V Kortenska , Rumiana G Mitreva
Journal of Cerebral Blood Flow and Metabolism 31 ( 4) 1107 -1118

27
2011
Age-dependence of sensorimotor and cerebral electroencephalographic asymmetry in rats subjected to unilateral cerebrovascular stroke

Slavianka G Moyanova , Rumiana G Mitreva , Lidia V Kortenska , Ferdinando Nicoletti
Experimental & Translational Stroke Medicine 5 ( 1) 13 -13

7
2013
Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status

Roberta Celli , Ines Santolini , Gilles Van Luijtelaar , Richard T Ngomba
Expert Opinion on Therapeutic Targets 23 ( 4) 341 -351

13
2019
Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death

Giuseppe Battaglia , Valeria Bruno , Richard T Ngomba , Renato Di Grezia
European Journal of Pharmacology 356 ( 2-3) 271 -274

65
1998
Is there a future for mGlu5-positive allosteric modulators in absence epilepsy? A comparison with Ethosuximide

Gilles van Luijtelaar , Valerio D’Amore , Ines Santolini , Richard T Ngomba
mGLU Receptors 207 -224

4
2017
Group I metabotropic glutamate receptor-mediated long term depression is disrupted in the hippocampus of WAG/Rij rats modelling absence epilepsy

Gabriele Di Cicco , Emanuela Marzano , Luisa Iacovelli , Roberta Celli
Neuropharmacology 196 108686 -108686

3
2021
Network analysis reveals a role of the hippocampus in absence seizures: The effects of a cannabinoid agonist

Marina V Sysoeva , Galina D Kuznetsova , Ilya V Sysoev , Richard T Ngomba
Epilepsy Research 192 107135 -107135

2023
2014
Expression of OP4 (ORL1, NOP1) receptors in vascular endothelium.

Filippo Granata , Rossella Luisa Potenza , Anna Fiori , Roberto Strom
European Journal of Pharmacology 482 ( 1) 17 -23

19
2003
Questions on cannabinoids: absence epilepsy and the CB1-receptor

R.T. Ngomba , R.F. Struik , C.M. van Rijn
FENS Abstracts

2010
WAG/Rij rats as a model to unravel the role of mglu receptors in absence epilepsy

R.T. Ngomba , E.L.J.M. van Luijtelaar
Neuropharmacology 55 628 -628

2008
Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats.

V. D'Amore , I. Santolini , C.M. van Rijn , F. Biagioni
Neuropharmacology 66 330 -338

21
2013
Protective role for type-1 metabotropic glutamate receptors against spike and wave discharges in the WAG/Rij rat model of absence epilepsy

R.T. Ngomba , I. Santolini , F. Biagioni , G. Molinaro
Neuropharmacology 60 ( 7) 1281 -1291

36
2011
Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG/Rij rats

V. D'Amore , I. Santolini , R. Celli , L. Lionetto
Neuropharmacology 85 91 -103

18
2014
60
2005
Positive allosteric modulation of metabotropic glutamate 4 (mGlu4) receptors enhances spontaneous and evoked absence seizures.

R.T. Ngomba , F. Ferraguti , A. Badura , R. Citraro
Neuropharmacology 54 ( 2) 344 -354

44
2008
36
2003